Company Filing History:
Years Active: 2022
Title: Innovator Hitoshi Ozasa and His Contributions to Medical Devices
Introduction
Hitoshi Ozasa, an innovative inventor based in Settsu, Japan, has made significant strides in the field of medical technology. His work primarily focuses on the development of devices that improve patient care and medical procedures, showcasing the essence of ingenuity in healthcare solutions.
Latest Patents
Ozasa holds a patent for a novel vascular embolization device. This device incorporates a coil with a primary shape and a stretch-resistant wire placed inside the coil. The unique feature of this wire is its multilayer construction, which consists of at least one core layer made from a material possessing a tensile break strength that exceeds that of the outer layer. The outer layer is designed using one or more resin compositions alongside a biochemical active material. This innovative vascular embolization device not only facilitates the administration of a biochemical active material but also exhibits excellent flexibility, enhancing its efficacy in medical applications.
Career Highlights
Hitoshi Ozasa is affiliated with Kaneka Medix Corporation, a company renowned for its commitment to health and medical innovations. Through his role at Kaneka Medix, Ozasa has played a pivotal part in advancing medical devices that prioritize patient safety and operational efficiency.
Collaborations
In his professional journey, Ozasa has collaborated with notable colleagues such as Atsushi Ogawa and Yasushi Yamanaka. Their combined expertise has further propelled developments in the field of vascular medical devices, reinforcing the importance of teamwork in scientific innovation.
Conclusion
With his inventive approach and dedication, Hitoshi Ozasa continues to contribute to the evolution of vascular embolization technology. His work at Kaneka Medix Corporation and the advancement of his patented device underline the critical role of inventors in transforming healthcare practices for better patient outcomes.